Trial Search Results

Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content

The purpose of this multi-site research is to validate a rapid magnetic resonance based confounder-corrected R-2 mapping method as a quantitative imaging biomarker of liver iron concentrations.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

University of Wisconsin, Madison

Collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Stanford Investigator(s):


  • Other: MRI


Inclusion Criteria:

   - know or suspected iron overload

Exclusion Criteria:

   - contraindication to magnetic resonance imaging

Ages Eligible for Study

10 Years - 89 Years

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Elisabeth Merkel, RN